Figure 2From: Efficacy and safety of widely used treatments for macular oedema secondary to retinal vein occlusion: a systematic review Potential comparisons between ranibizumab and other treatments for (a) BRVO and (b) CRVO. BRVO, branch retinal vein occlusion; CRVO, central retinal vein occlusion; IVT, intravitreal triamcinolone.Back to article page